335 related articles for article (PubMed ID: 21165527)
1. The evolving role of the community pharmacist in chronic disease management - a literature review.
George PP; Molina JA; Cheah J; Chan SC; Lim BP
Ann Acad Med Singap; 2010 Nov; 39(11):861-7. PubMed ID: 21165527
[TBL] [Abstract][Full Text] [Related]
2. The development of a role description and competency map for pharmacists in an interprofessional care setting.
Benson H; Lucas C; Benrimoj SI; Williams KA
Int J Clin Pharm; 2019 Apr; 41(2):391-407. PubMed ID: 30879217
[TBL] [Abstract][Full Text] [Related]
3. Patient self-management and pharmacist-led patient self-management in Hong Kong: a focus group study from different healthcare professionals' perspectives.
Wong FY; Chan FW; You JH; Wong EL; Yeoh EK
BMC Health Serv Res; 2011 May; 11():121. PubMed ID: 21609422
[TBL] [Abstract][Full Text] [Related]
4. Community pharmacists' role in caring for people living with epilepsy: A scoping review.
Bacci JL; Zaraa S; Stergachis A; Simic G; White HS
Epilepsy Behav; 2021 Apr; 117():107850. PubMed ID: 33631435
[TBL] [Abstract][Full Text] [Related]
5. Impact of community pharmacist-led interventions in chronic disease management on clinical, utilization, and economic outcomes: An umbrella review.
Newman TV; San-Juan-Rodriguez A; Parekh N; Swart ECS; Klein-Fedyshin M; Shrank WH; Hernandez I
Res Social Adm Pharm; 2020 Sep; 16(9):1155-1165. PubMed ID: 31959565
[TBL] [Abstract][Full Text] [Related]
6. A national survey exploring oral healthcare service provision across Australian community pharmacies.
Freeman CR; Abdullah N; Ford PJ; Taing MW
BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
[TBL] [Abstract][Full Text] [Related]
7. Solidarity or dissonance? A systematic review of pharmacist and GP views on community pharmacy services in the UK.
Hindi AMK; Jacobs S; Schafheutle EI
Health Soc Care Community; 2019 May; 27(3):565-598. PubMed ID: 30047617
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of pharmacist input to metabolic syndrome screening, management and prevention.
Al AdAwi RM; Stewart D; Ryan C; Tonna AP
Int J Clin Pharm; 2020 Aug; 42(4):995-1015. PubMed ID: 32607719
[TBL] [Abstract][Full Text] [Related]
9. Consumer, physician, and payer perspectives on primary care medication management services with a shared resource pharmacists network.
Smith M; Cannon-Breland ML; Spiggle S
Res Social Adm Pharm; 2014; 10(3):539-53. PubMed ID: 24055137
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
Wibowo Y; Parsons R; Sunderland B; Hughes J
Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
[TBL] [Abstract][Full Text] [Related]
11. Pharmacists' medicines-related interventions for people with intellectual disabilities: a narrative review.
O'Dwyer M; Meštrović A; Henman M
Int J Clin Pharm; 2015 Aug; 37(4):566-78. PubMed ID: 25903938
[TBL] [Abstract][Full Text] [Related]
12. The role of pharmacist in community palliative care-a scoping review.
Thrimawithana TR; Spence M; Lee M; Naysoe N; Hanna S; Yako G; Goma S; Stupans I; Lim CX
Int J Pharm Pract; 2024 May; 32(3):194-200. PubMed ID: 38584472
[TBL] [Abstract][Full Text] [Related]
13. Diabetes and cardiovascular disease interventions by community pharmacists: a systematic review.
Evans CD; Watson E; Eurich DT; Taylor JG; Yakiwchuk EM; Shevchuk YM; Remillard A; Blackburn D
Ann Pharmacother; 2011 May; 45(5):615-28. PubMed ID: 21558487
[TBL] [Abstract][Full Text] [Related]
14. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
[TBL] [Abstract][Full Text] [Related]
15. Pharmacist involvement in improving asthma outcomes in various healthcare settings: 1997 to present.
Benavides S; Rodriguez JC; Maniscalco-Feichtl M
Ann Pharmacother; 2009 Jan; 43(1):85-97. PubMed ID: 19109213
[TBL] [Abstract][Full Text] [Related]
16. A meta-narrative review of recorded patient-pharmacist interactions: exploring biomedical or patient-centered communication?
Murad MS; Chatterley T; Guirguis LM
Res Social Adm Pharm; 2014; 10(1):1-20. PubMed ID: 23608702
[TBL] [Abstract][Full Text] [Related]
17. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland.
Weidmann AE; MacLure K; Marshall S; Gray G; Stewart D
Int J Clin Pharm; 2015 Aug; 37(4):599-606. PubMed ID: 25822039
[TBL] [Abstract][Full Text] [Related]
18. Medication management for community palliative care patients and the role of a specialist palliative care pharmacist: A qualitative exploration of consumer and health care professional perspectives.
Kuruvilla L; Weeks G; Eastman P; George J
Palliat Med; 2018 Sep; 32(8):1369-1377. PubMed ID: 29793391
[TBL] [Abstract][Full Text] [Related]
19. Community pharmacist-led clinical services: physician's understanding, perceptions and readiness to collaborate in a Midwestern state in the United States.
Gordon C; Unni E; Montuoro J; Ogborn DB
Int J Pharm Pract; 2018 Oct; 26(5):407-413. PubMed ID: 29218803
[TBL] [Abstract][Full Text] [Related]
20. Intervention research to enhance community pharmacists' cognitive services: a systematic review.
Patwardhan PD; Amin ME; Chewning BA
Res Social Adm Pharm; 2014; 10(3):475-93. PubMed ID: 24071523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
